These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2903800)

  • 1. [Cardioprotective and membrane effects of exaprolol].
    Cesk Fysiol; 1986; 35(5):478-80. PubMed ID: 2903800
    [No Abstract]   [Full Text] [Related]  

  • 2. Exaprolol as a modulator of heart sarcolemmal (Na+ + K+)-ATPase. Evidence for interaction with an essential sulfhydryl group in the catalytic centre of the enzyme.
    Dzurba A; Ziegelhöffer A; Schmidtová L; Breier A; Vrbjar N; Okolicány J
    Gen Physiol Biophys; 1985 Jun; 4(3):257-64. PubMed ID: 2863195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of exaprolol upon the ischaemic rat heart and its interaction with sarcolemmal (Na+ + K+)-ATPase.
    Dzurba A; Barta E; Styk J; Okolicány J; Ziegelhöffer A
    Physiol Bohemoslov; 1989; 38(1):29-39. PubMed ID: 2566182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a new beta-adrenoceptor blocking agent, carteolol (OPC-1085). Improvement of the coronary collateral circulation in dogs with chronic coronary artery occlusion (author's transl)].
    Ishihara T; Watanabe K; Takenaka F
    Arzneimittelforschung; 1977; 27(11):2055-9. PubMed ID: 23789
    [No Abstract]   [Full Text] [Related]  

  • 5. The cardiovascular effects of celiprolol in healthy volunteers and patients with coronary heart disease.
    Hitzenberger G
    Br J Clin Pract Suppl; 1985 Jun; 40():46-51. PubMed ID: 2864064
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of exaprolol and sodium salicylate on erythrocyte hemolysis in relation to age].
    Linková A; Nicák A
    Bratisl Lek Listy; 1990 Jan; 91(1):52-6. PubMed ID: 1969763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic effect of exaprolol and its dependence on the age of rats].
    Nicák A; Linková A; Kohút A
    Bratisl Lek Listy; 1982 Nov; 78(5):554-9. PubMed ID: 6129052
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dl-erythro-1-phenoxy-3-[(3,4-dimethoxyphenethyl)-amino]-butan-2-ol (PS-6) on rat heart sarcolemma.
    Takeo S; Daly MJ; Tuana BS; Somani P; Dhalla NS
    Arzneimittelforschung; 1980; 30(9):1511-3. PubMed ID: 6257250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium.
    Evans DB; Parham CS; Laffan RJ
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):240-8. PubMed ID: 41496
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects of celiprolol and metoprolol on left ventricular volume in coronary artery disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pract Suppl; 1985 Jun; 40():45. PubMed ID: 2864063
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of a new beta blockader (SD/1601) on positive levelling of the ST epicardial tracing during coronary occlusion in the narcotized dog].
    Merlo L; Brusoni B; Minoia G; Marchetti G
    Boll Soc Ital Biol Sper; 1977 Mar; 53(6):440-4. PubMed ID: 20906
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of sarcolemmal ATPase and pNPPase by CH-103.
    Nosztray K; Szabó J; Varga E; Szegi J
    Acta Physiol Hung; 1990; 75 Suppl():225-6. PubMed ID: 1973566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transmural coronary blood flow redistribution in the non-ischemic and ischemic canine myocardium with S 2395, a beta-adrenoceptor blocking agent (author's transl)].
    Berdeaux PA; Giudicelli JF
    Arch Farmacol Toxicol; 1980 Dec; 6(3):209-24. PubMed ID: 6118102
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

  • 15. Atenolol, regional myocardial blood flow and S-T segment in canine ischaemic myocardium [proceedingins].
    Berdeaux A; Boissier JR; Giudicelli JF
    Br J Pharmacol; 1976 Nov; 58(3):411P. PubMed ID: 11019
    [No Abstract]   [Full Text] [Related]  

  • 16. Atenolol, exaprolol and mast cell membranes.
    Pecivová J; Drábiková K; Jancinová V; Petríková M; Nosál R
    Agents Actions; 1991 May; 33(1-2):41-3. PubMed ID: 1680276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 18. Negative inotropic effects of esmolol.
    Jacobs JR
    Anesth Analg; 1989 Jan; 68(1):72-3. PubMed ID: 2562911
    [No Abstract]   [Full Text] [Related]  

  • 19. Celiprolol: a haemodynamic appraisal in comparison with propranolol.
    Solomon T; Gensini G; Dator C; Caruso F
    Br J Clin Pract Suppl; 1985 Jun; 40():43-4. PubMed ID: 2864062
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].
    Boudot JP; Cavero I; Fénard S; Lefèvre-Borg F; Manoury P; Roach AG
    Br J Pharmacol; 1979 Jul; 66(3):445P. PubMed ID: 43176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.